IPO registrations (S-1, F-1) · Registrants
SYNLOGIC, INC.
- SEC CIK
- 1527599 · filings on EDGAR ↗
- Former names
- Mirna Therapeutics, Inc. (2011–2017)
- Registration
- Form S-1, first filed 2015-08-24, last 2023-09-28; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2015-10-01; declared effective 2015-09-30
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- PO BOX 30, Winchester, MA 01890
- EIN
- 26-1824804
- Ticker
- SYBX (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- SYNLOGIC, INC. on the corporate pages
Offering terms
- Final price
- $7.00 per share (424B4 filed 2015-10-01, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $43,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MIRN
- Lead underwriters
- Citigroup; Leerink Partners
- Syndicate
- Oppenheimer; Cantor Fitzgerald
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: MIRNA THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Form D issuer: SYNLOGIC, INC. EXACT (CIK (EXACT))
- SEC filer: Mirna Therapeutics, Inc. EXACT (CIK (EXACT))
- Person page: Elaine V Jones Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Jose-Carlos Gutierrez-Ramos Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: Krishna Kittu Kolluri Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: Richard P Shea Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 20
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-08-24 | S-1 | S-1 (registration) | Mirna Therapeutics, Inc. | 0001047469-15-006962 ↗ |
| 2015-09-11 | S-1/A | S-1/A (amendment) | Mirna Therapeutics, Inc. | 0001047469-15-007251 ↗ |
| 2015-09-18 | S-1/A | S-1/A (amendment) | Mirna Therapeutics, Inc. | 0001047469-15-007386 ↗ |
| 2015-09-25 | S-1/A | S-1/A (amendment) | Mirna Therapeutics, Inc. | 0001047469-15-007528 ↗ |
| 2015-09-29 | S-1/A | S-1/A (amendment) | Mirna Therapeutics, Inc. | 0001047469-15-007595 ↗ |
| 2015-09-30 | S-1/A | S-1/A (amendment) | Mirna Therapeutics, Inc. | 0001047469-15-007609 ↗ |
| 2015-09-30 | EFFECT | EFFECT (declared effective) | Mirna Therapeutics, Inc. | 9999999995-15-002634 ↗ |
| 2015-10-01 | 424B4 | 424B4 (final prospectus) | Mirna Therapeutics, Inc. | 0001047469-15-007634 ↗ |
| 2017-07-13 | EFFECT | EFFECT (declared effective) | Mirna Therapeutics, Inc. | 9999999995-17-001811 ↗ |
| 2017-10-25 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-17-002786 ↗ |
| 2018-08-30 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-18-002248 ↗ |
| 2019-09-13 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-19-002090 ↗ |
| 2021-07-30 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-21-003011 ↗ |
| 2023-09-08 | S-1 | S-1 (registration) | SYNLOGIC, INC. | 0001193125-23-231524 ↗ |
| 2023-09-27 | S-1/A | S-1/A (amendment) | SYNLOGIC, INC. | 0001193125-23-242769 ↗ |
| 2023-09-28 | S-1/A | S-1/A (amendment) | SYNLOGIC, INC. | 0001193125-23-244819 ↗ |
| 2023-09-28 | S-1MEF | S-1MEF (added securities) | SYNLOGIC, INC. | 0001193125-23-246091 ↗ |
| 2023-09-28 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-23-002818 ↗ |
| 2023-10-02 | 424B4 | 424B4 (final prospectus) | SYNLOGIC, INC. | 0001193125-23-249173 ↗ |
| 2025-08-20 | EFFECT | EFFECT (declared effective) | SYNLOGIC, INC. | 9999999995-25-002691 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | S-1/A | registration statement | $7.00 | 6,250,000 | $43,750,000 | Nasdaq MIRN | 4 | primary document; price sentence, shares headline, proceeds computed, cover names 4 | document ↗ | |
| 2015-10-01 | 424B4 | final prospectus | $7.00 | 6,250,000 | $43,750,000 | Nasdaq MIRN | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | TenPercentOwner | 2 | 2015 | ||
| Alleva Lawrence M | Director | 4 | 2015–2016 | ||
| Barbosa Miguel | Officer | Chief Scientific Officer | 2 | 2015 | |
| BARRETT M JAMES | TenPercentOwner | 4 | 2015–2018 | ||
| BARRIS PETER J | TenPercentOwner | 4 | 2015–2018 | ||
| BASKETT FOREST | TenPercentOwner | 5 | 2015–2023 | ||
| DeYoung Casi | Officer | Chief Business Officer | 3 | 2015–2016 | |
| Florence Anthony A. Jr. | Director,TenPercentOwner; TenPercentOwner | 6 | 2015–2026 | ||
| Fuhrman Alan | Officer | Chief Financial Officer | 3 | 2015–2016 | |
| HEALY JAMES | TenPercentOwner | 2 | 2015 | ||
| Irvin Jon | Officer | Vice President, Finance | 8 | 2015–2016 | |
| Jones Elaine V | Director | 2 | 2015 | person page Fuzzy | |
| KERINS PATRICK J | TenPercentOwner | 5 | 2015–2023 | ||
| Kim Sinil | Officer | Chief Medical Officer | 3 | 2015–2016 | |
| KOLLURI KRISHNA KITTU | TenPercentOwner | 2 | 2015 | person page Fuzzy | |
| Lammers Paul | Director,Officer | President & CEO | 3 | 2015–2016 | |
| Mathers Edward T | Director | 11 | 2015–2023 | ||
| Mehra Anand | TenPercentOwner | 2 | 2015 | ||
| MOTT DAVID M | TenPercentOwner | 4 | 2015–2018 | ||
| NEA 14 GP, LTD | Director,TenPercentOwner; TenPercentOwner | 5 | 2015–2026 | ||
| NEA Partners 14, L.P. | Director,TenPercentOwner; TenPercentOwner | 5 | 2015–2026 | ||
| New Enterprise Associates 14, L.P. | Director,TenPercentOwner; TenPercentOwner | 6 | 2015–2026 | ||
| PFIZER INC | TenPercentOwner | 2 | 2015 | ||
| POWELL MICHAEL | Director; Director,TenPercentOwner | 9 | 2015–2019 | ||
| SANDELL SCOTT D | Director,TenPercentOwner; TenPercentOwner | 6 | 2015–2026 | ||
| SIEGALL CLAY B | Director | 3 | 2015–2016 | ||
| Sofinnova Management VIII, L.L.C. | TenPercentOwner | 2 | 2015 | ||
| Sofinnova Venture Partners VIII, L.P. | TenPercentOwner | 2 | 2015 | ||
| Sonsini Peter W. | TenPercentOwner | 4 | 2015–2018 | ||
| Viswanathan Ravi | TenPercentOwner | 4 | 2015–2018 | ||
| Weller Harry R | TenPercentOwner | 2 | 2015 | ||
| Winkler Matthew | Director | 4 | 2015–2016 | ||
| Cancer Prevention & Research Institute of Texas | TenPercentOwner | 1 | 2015 | ||
| Greenleaf Peter | Director | 4 | 2016 | ||
| O'Neill Vincent | Officer | Chief Medical Officer | 2 | 2016 | |
| Nisen Perry | Director | 2 | 2016 | ||
| Atlas Venture Fund IX, L.P. | TenPercentOwner | 1 | 2017 | ||
| Barrett Peter | Director | 16 | 2017–2024 | ||
| Brennan Aoife | Director,Officer; Officer | Chief Medical Officer; Interim President and CEO; President and CEO; See Remarks | 12 | 2017–2023 | |
| Gutierrez-Ramos Jose-Carlos | Director,Officer | See Remarks | 3 | 2017–2018 | person page Fuzzy |
| ISALY SAMUEL D | Director | 1 | 2017 | ||
| Khuong Chau Quang | Director | 8 | 2017–2021 | ||
| Leschly Nick | Director | 9 | 2017–2023 | ||
| Miller Paul Francis | Officer | Chief Scientific Officer | 9 | 2017–2019 | |
| ORBIMED ADVISORS LLC | Director | 3 | 2017–2021 | ||
| OrbiMed Capital GP VI LLC | Director | 3 | 2017–2021 | ||
| Shea Richard P | Director | 11 | 2017–2025 | person page Fuzzy | |
| Shegog Todd | Officer | See Remarks | 3 | 2017–2019 | |
| Gengos Andrew | Officer | Chief Operating Officer; See Remarks | 3 | 2017–2018 | |
| Hurter Patricia N. | Director | 9 | 2019–2024 | ||
| PLEVY SCOTT ERIC | Officer | Chief Scientific Officer | 3 | 2019 | |
| Ginkgo Bioworks, Inc. | TenPercentOwner | 1 | 2019 | ||
| Riese Richard J. | Officer | Chief Medical Officer | 5 | 2019–2021 | |
| BELOFF GREGG | Officer | See Remarks | 3 | 2019–2022 | |
| Burgess Michael F. | Director | 6 | 2020–2023 | ||
| Awad Antoine | Officer | Chief Operating Officer | 7 | 2020–2024 | |
| Heffernan Michael Thomas | Director | 5 | 2020–2023 | ||
| Kelly-Croswell Lisa | Director | 5 | 2021–2023 | ||
| JENSEN MICHAEL VANGSTED | Officer | Chief Financial Officer | 5 | 2022–2023 | |
| Cable Car Capital LLC | Other | 1 | 2024 | ||
| Funicular Funds, LP | TenPercentOwner | 1 | 2024 | ||
| Ma-Weaver Jacob | Other | 1 | 2024 | ||
| Dooley Mary Beth | Officer | Head of Finance; See Remarks below | 6 | 2024–2025 | |
| Flynn James P | Director | 3 | 2024–2025 | ||
| Makhzoumi Mohamad | Director,TenPercentOwner | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-06-18 | SYNLOGIC, INC. | Biotechnology | $79,999,992 | $79,999,992 | 1 | 1 |
| 2015-05-01 | Mirna Therapeutics, Inc. | Pharmaceuticals | $45,000,000 | $41,789,527 | 24 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | SYNLOGIC, INC. | MA | Form D private offerings | CIK (EXACT) |
| Form D issuer | SYNLOGIC, INC. | MA | Form D private offerings | name and state |
| Form D issuer | Synlogic, LLC | MA | Form D private offerings | name and state |
| Patent assignee | Synlogic, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | SYNLOGIC, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Synlogic, Inc. | MA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | MIRNA THERAPEUTICS, INC. | EIN (EXACT) | ||
| Person page | Elaine V Jones | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Jose-Carlos Gutierrez-Ramos | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) | |
| Person page | Krishna Kittu Kolluri | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | Richard P Shea | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.